Goodrx Holdings Inc (GDRX) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.47x

Goodrx Holdings Inc (GDRX) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting $36.00 Million (capex $18.00 Million plus investments $-18.00 Million) from operating cash flow of $76.02 Million. Check GDRX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.47x
(Capex + Investments) / Operating CF

Total Reinvested

$36.00 Million
Capex + Investments

Operating Cash Flow

$76.02 Million
USD

Capital Expenditures

$18.00 Million
USD

Goodrx Holdings Inc Cash Flow Reinvestment Rate (2018–2024)

Historical reinvestment intensity for Goodrx Holdings Inc across 7 annual periods. Explore cash flow to debt ratio of Goodrx Holdings Inc to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Goodrx Holdings Inc (2018–2024)

Year-by-year capital reinvestment analysis for Goodrx Holdings Inc. For live market cap and broader valuation context, see GDRX stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.77x $140.69 Million $183.89 Million $70.35 Million ▲ +8.7%
2023 0.70x $97.37 Million $138.29 Million $55.77 Million ▼ -61.1%
2022 1.81x $265.71 Million $146.78 Million $55.21 Million ▲ +51.8%
2021 1.19x $213.19 Million $178.78 Million $34.46 Million ▲ +22.9%
2020 0.97x $127.44 Million $131.34 Million $35.82 Million ▲ +88.8%
2019 0.51x $42.80 Million $83.29 Million $5.75 Million ▲ +236.3%
2018 0.15x $6.92 Million $45.25 Million $3.46 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow